XML 13 R3.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Balance Sheets (Parenthetical) - USD ($)
shares in Thousands, $ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Net investment in sales-type leases, allowances $ 7,697 $ 6,821
Ground Lease receivables, allowances 5,213 3,664
Loans receivable, net - related party, allowances $ 2,194 $ 2,311
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, shares authorized (in shares) 400,000 400,000
Common stock, shares issued (in shares) 71,723 71,440
Common stock, shares outstanding (in shares) 71,723 71,440
Deferred expenses and other assets, net [1],[2] $ 89,533 $ 105,015
Related party    
Deferred expenses and other assets, net $ 3,700 $ 3,800
[1] As of March 31, 2025 and December 31, 2024, includes $3.7 million and $3.8 million, respectively, due from related parties.
[2] Refer to Note 2 for details on the Company’s consolidated variable interest entities (“VIEs”).